Hepatocellular Carcinoma Showing Tumor Shrinkage Due to an Abscopal Effect

Yano, Ryo; Hirooka, Masashi; Morita, Makoto; Okazaki, Yuki; Nakamura, Yoshiko; Imai, Yusuke; Watanabe, Takao; Yoshida, Osamu; Terada, Yoshio; Abe, Masanori; Hiasa, Yoichi

doi:10.2169/internalmedicine.1844-23

Cited by 4 publications

(1 citation statement)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Clinical application of the abscopal effect in HCC still lies in its infancy, with a long way to go, although the continuous investigations are aimed at the optimization of radiation protocols and combinations with immunotherapies, which would reliably induce the phenomenon in practice. Further study on the molecular and immunological profile of HCC is critical in tailoring treatment strategies, based on exploiting the abscopal effect with hope for overall improvements in the management of patients [ 58 , 59 ].…”

Section: Combination Of Radiotherapy and Immunotherapymentioning

confidence: 99%

Immunotherapy and Radiation Therapy Combinatorial Approaches in Hepatocellular Carcinoma

Tojjari,

Yu,

Saeed

2024

Cancers

View full text Add to dashboard Cite

Hepatocellular carcinoma (HCC), a prevalent and often fatal liver cancer, presents significant treatment challenges, especially in its advanced stages. This article delves into the promising approach of combining immunotherapy, particularly immune checkpoint inhibitors, with radiation therapy, a cornerstone of HCC management. Our review synthesizes current preclinical and clinical research, highlighting the potential synergistic effects of this combinational treatment. Emerging evidence suggests that this synergy enhances tumor control and improves patient survival rates. The combination leverages the localized, tumor-targeting ability of radiation therapy and the systemic, immune-boosting effects of immunotherapy, potentially overcoming the limitations inherent in each treatment modality when used separately. This integrative approach is especially promising in addressing the complex tumor microenvironment of HCC. However, the treatment landscape is nuanced, with challenges such as patient-specific response variability and potential resistance to therapies. Future research directions should focus on refining these combination strategies, tailoring them to individual patient profiles, and understanding the underlying mechanisms that govern the interaction between immunotherapy and radiation therapy. Such advancements could significantly improve HCC management, setting new standards for patient care and treatment efficacy.

show abstract

Section: Combination Of Radiotherapy and Immunotherapymentioning

confidence: 99%